Pharma Focus Europe

LATEST NEWSRead more...

12

Jul 2024

Pan Cancer T Secures €4.25 Million to Advance Next-Generation T Cell Therapies in Seed Extension Round

Pan Cancer T BV a biotech startup focusing on advancing T cell therapies for solid cancers has successfully closed a million Seed Extension round This funding includes

12

Jul 2024

11

Jul 2024

AusperBio's AHB-137 Receives Breakthrough Therapy Designation for Chronic Hepatitis B Treatment

AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd have announced that their investigational drug AHB has received Breakthrough Therapy Designation

11

Jul 2024

XyloCor and SmartCella Collaborate on License Agreement for Extroducer in Novel Gene Therapy XC001 Targeting Heart Treatment

XyloCor Therapeutics Inc a company advancing gene therapies for cardiovascular diseases has partnered with SmartWise a unit of SmartCella Holding AB to license the Extroducer Infusion Catheter

10

Jul 2024

Curium Submits NDA for Lutetium Lu 177 Dotatate Injection

Curium a leader in nuclear medicine announced today the submission of a b New Drug Application for Lutetium Lu Dotatate Injection This application seeks FDA approval for treating somatostatin receptorpositive gastroenteropancreatic neuroendocrine tumors

09

Jul 2024

Abata Therapeutics Gets FDA Approval to Start Clinical Trials of ABA-101 for Progressive Multiple Sclerosis

Abata Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug application to conduct a Phase study of ABA in patients

press releasesRead more...

Ipsen and Foreseen Biotechnology Announce Exclusive Worldwide License Agreement for Antibody-Drug Conjugate with First-in-Class Potential

Ipsen and Foreseen Biotechnology today announced the signing of an exclusive worldwide license agreement for FS a potentially firstinclass antibodydrug

Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron

Pfizer Inc today announced that based on results from the ongoing pharmacokinetic study the company has selected its preferred oncedaily modified release formulation for danuglipron

Evotec and Pfizer Collaborate to Advance Drug Discovery in France

Evotec SE today announced it has entered into a multiyear master research collaboration and option and license agreement with Pfizer Under the agreement Evotec and Pfizer will initially focus on early discovery research for metabolic

Oxford Drug Design Announces Initial in Vivo Validation of Novel Oncology Therapeutic Mechanism

Oxford Drug Design the Oxfordbased AI drug discovery company applying its pioneering AI platform to develop novel molecules for use in cancer treatments has successfully completed the first in vivo validation

18 - 20

Jul 2024

Pharma India Expo 2024

Telangana, India

29 - 31

Jul 2024

16 - 17

Aug 2024

iPharma Expo 2024

Boston, USA

21 - 22

Aug 2024

22 - 24

Aug 2024
Thermo Fisher Scientific - mRNA Services
World Orphan Drug Congress 2024
World Vaccine Congress Europe 2024
Advanced Therapies USA 2024
cytiva

TOP ARTICLES

  • 1

    How Drug Patents Shape the Competitive Landscape in Pharma?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    Pharmaceutical Marketing in the Digital Age: Strategies and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    The Role of Technology in Enhancing Patient Acceptance and Satisfaction

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Innovative Solutions: Cell and Gene Therapy's Impact on Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    Drug Safety in Focus: Challenges and Solutions for Pharma Companies

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION